-
-
-
-
-
-
-
ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual Meeting
-
-
-
-
-
-
-
Trading Radar for 05/07: Tesla (TSLA), Zillow (Z), Humana (HUM), Coupons.com (COUP), GT Advanced Technologies (GTAT)
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

